Grants and Contributions

The CIHR Institute of Gender and Health (CIHR-IGH) will fund applications that are relevant to its mandate and research priorities, as described in our new Research Priority Plan, and that are aligned with at least one of the following research areas.
Research Areas:
1. Advancing intersectionality in sex and gender science (1 grant)
2. Understanding sex and gender mechanisms and processes (1 grant)
3. Sex and gender science for health equity in priority communities (2 grants)

Designing, implementing and/or evaluating equitable, accessible, anti-ableist, anti-racist, anti-discriminatory, diverse and/or inclusive health care delivery systems and/or service delivery models that advance the Quadruple Aim and health equity for all;
4.

The CIHR Institute of Infection and Immunity (CIHR-III) will fund applications that are determined to be specifically relevant to its mandate and its 2021-2026 Strategic Plan, with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.

This Priority Announcement will prioritize funding for research in the following research areas:

• Infection:
o Zoonotic or vector-borne transmission of pathogens in the context of Global Climate Change;
o Understanding functional genomics and/or molecular epidemiology of emerging/re-emerging pathogens;
o Resistance to fungal infections and/or the role of bacteriophages in combatting antimicrobial resistance (AMR).
• Immunity:
o Immune mechanisms involved in the development of trained innate immunity;
o Immune mechanisms involved in the development and maintenance of tissue-specific immunity;
o Metabolic regulation of immune cells and processes (immunometabolism).

Should there be no eligible applications relevant to the research areas identified above, III will fund applications that are relevant to its mandate and its 2021-2026 Strategic Plan, with a primary focus on biomedical research in which the objective and aims are directed towards building foundational knowledge in immunology and/or infectious diseases.

The Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE) is housed at CIHR with a mandate to grow Canada's research leadership in preparedness, prevention, response, and recovery from pandemics and public health emergencies, including by building and supporting Canadian research capacity in the field.

CRPPHE will offer funding for bridge grants to research projects that are aligned with the CRPPHE goal and objectives and the CRPPHE Interim Investment Plan 2023-2025, and that have a primary research objective related to preparing for and/or responding to existing and future pandemics and other health emergencies*.

The CIHR HIV/AIDS and Sexually Transmitted and Blood-Borne Infections (STBBI) Research Initiative, under the leadership of the CIHR Institute of Infection and Immunity (CIHR-III), defines STBBI as infections that are transmitted primarily through exchange of body fluids during sexual contact and/or through blood, and supports projects with a primary focus on STBBI of public health relevance, including but not limited to HIV/AIDS, chlamydia, gonorrhea, syphilis, hepatitis B, hepatitis C and human papillomavirus. This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.

Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.

In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the Research Initiative champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.

This Priority Announcement will prioritize funding for research on HIV/AIDS and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:

• Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
• Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.